Barcellini, W., & Fattizzo, B. (2015). Clinical applications of hemolysis markers in the differential diagnosis and management of hemolytic anemia. Diseases, 3(2), 126–143. https://doi.org/10.3390/diseases3020126
Luzzatto, L., & Arese, P.(2018). Favism and Glucose-6-Phosphate Dehydrogenase Deficiency. New England Journal of Medicine, 378, 60-71. https://doi.org/10.1056/NEJMra1704093
Chonat, S., & Quinn, C. T. (2017). Current standards of care and long-term outcomes for thalassemia and sickle cell disease. Current Pediatric Reviews, 13(1), 55-66. https://doi.org/10.2174/1573396313666170223165527
Garratty, G. (2009). Immune hemolytic anemia associated with drug therapy. Blood Reviews, 23(1), 17-27. https://doi.org/10.1016/j.blre.2008.04.001
